Arriving in the arena of obesity treatment, retatrutide presents a unique approach. Unlike many current medications, retatrutide operates as a dual agonist, at once affecting both GLP-like peptide-1 (GLP-1) and https://arunrekc528964.blogaritma.com/36661087/the-novel-retatrutide-the-glp-gip-receptor-agonist